Literature DB >> 12902584

Tetracycline treatment does not eradicate Mycoplasma genitalium.

L Falk1, H Fredlund, J S Jensen.   

Abstract

OBJECTIVES: To study the treatment efficacy of tetracyclines and azithromycin in Mycoplasma genitalium positive patients attending an STD clinic.
METHODS: All M genitalium positive patients (34 men and 26 women) attending an STD clinic during a 6 month period were treated with antibiotics. All patients known to be partners of M genitalium positive patients and those who were M genitalium positive, but not initially treated, were treated with azithromycin. Patients with urethritis and/or cervicitis were treated with tetracyclines before their M genitalium status was known.
RESULTS: 10 of 14 women (71%) and 10 of 16 men (63%) treated with tetracyclines were M genitalium positive at follow up, whereas all patients treated with azithromycin (16 men and 20 women) were M genitalium negative, at the 4 week follow up visit.
CONCLUSIONS: These results suggest that tetracyclines are not sufficient to eradicate M genitalium. Randomised controlled treatment trials are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902584      PMCID: PMC1744713          DOI: 10.1136/sti.79.4.318

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  31 in total

1.  Sequence-based typing of Mycoplasma genitalium reveals sexual transmission.

Authors:  Sofie Vetli Hjorth; Eva Björnelius; Peter Lidbrink; Lars Falk; Birthe Dohn; Lene Berthelsen; Liang Ma; David H Martin; Jørgen Skov Jensen
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial.

Authors:  J R Schwebke; A Rompalo; S Taylor; A C Seña; D H Martin; L M Lopez; S Lensing; J Y Lee
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

3.  Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline.

Authors:  A Wikström; J S Jensen
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

4.  Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.

Authors:  Ryoichi Hamasuna; Yukio Osada; Jørgen Skov Jensen
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 5.  Mycoplasma genitalium: from Chrysalis to multicolored butterfly.

Authors:  David Taylor-Robinson; Jørgen Skov Jensen
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.

Authors:  Jørgen Skov Jensen; Prabhavathi Fernandes; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

7.  Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial.

Authors:  Lisa E Manhart; Catherine W Gillespie; M Sylvan Lowens; Christine M Khosropour; Danny V Colombara; Matthew R Golden; Navneet R Hakhu; Katherine K Thomas; James P Hughes; Nicole L Jensen; Patricia A Totten
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

8.  Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis.

Authors:  L Falk; H Fredlund; J S Jensen
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

9.  Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics.

Authors:  C Gaydos; N E Maldeis; A Hardick; J Hardick; T C Quinn
Journal:  Sex Transm Infect       Date:  2009-04-20       Impact factor: 3.519

10.  Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics.

Authors:  Charlotte Gaydos; Nancy E Maldeis; Andrew Hardick; Justin Hardick; Thomas C Quinn
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.